NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-04-15 18:40 English ZIP 8.4 KB
2025-04-15 18:30 English ZIP 8.4 KB
2025-04-15 18:22 English ZIP 8.4 KB
2025-04-15 18:18 English ZIP 8.4 KB
2025-04-15 18:11 English ZIP 8.1 KB
2025-04-07 22:30 English ZIP 7.6 KB
2025-04-02 23:17
FORM 10-K
English ZIP 2.7 MB
2025-04-01 01:01
FORM NT 10-K
English ZIP 11.7 KB
2025-03-19 21:33
FORM DEF 14A
English ZIP 599.2 KB
2025-03-11 21:35
FORM 8-K
English ZIP 195.2 KB
2025-03-07 13:08
FORM DEFA14A
English ZIP 76.2 KB
2025-03-07 13:07
FORM 8-K
English ZIP 172.7 KB
2025-02-18 23:25
FORM PRE 14A
English ZIP 583.5 KB
2025-02-07 00:30 English ZIP 10.5 KB
2025-02-04 22:58
FORM DEFA14A
English ZIP 19.2 KB

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Mind Medicine (MindMed) Inc. Logo
A clinical-stage biopharmaceutical company developing novel treatments for brain health disorders.
United States of America
MNMD
Mineralys Therapeutics, Inc. Logo
Clinical-stage biopharma developing medicines for aldosterone-driven diseases.
United States of America
MLYS
Minerva Neurosciences, Inc. Logo
Clinical-stage biopharma company developing treatments for central nervous system diseases.
United States of America
NERV
MiNK Therapeutics, Inc. Logo
Develops allogeneic iNKT cell therapies for cancer and immune-mediated diseases.
United States of America
INKT
MIRA PHARMACEUTICALS, INC. Logo
Clinical-stage pharma company developing therapies for neurologic/neuropsychiatric disorders.
United States of America
MIRA
Mirum Pharmaceuticals, Inc. Logo
Develops and commercializes therapies for rare, debilitating liver conditions.
United States of America
MIRM
Mithra Pharmaceuticals S.A. Logo
A biotech company developing drugs for contraception, fertility, and menopause.
Belgium
MITRA
MIZUHO MEDY CO.,LTD. Logo
Develops and manufactures in-vitro diagnostic products like immunoassays and gene tests.
Japan
4595
MOA Life Plus Co. Ltd. Logo
Develops biopharmaceuticals and consumer healthcare products using γ-PGA technology.
South Korea
142760
Moberg Pharma Logo
Pharmaceutical company developing and commercializing treatments for nail fungus.
Sweden
MOB

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.